The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcome of 117 patients with Erdheim-Chester disease and mixed histiocytosis receiving targeted therapies (BRAF and MEK inhibitors): A monocentric experience.
 
Fleur Cohen-Aubart
No Relationships to Disclose
 
Frédéric Charlotte
No Relationships to Disclose
 
Ahmed Idbaih
Consulting or Advisory Role - Health Advances
Research Funding - Air Liquide (Inst); Carthera (Inst); Sanofi (Inst); Transgene (Inst)
 
Stéphane Barete
No Relationships to Disclose
 
NeLa Benameur
No Relationships to Disclose
 
Jean-François Emile
Honoraria - Amgen; Bristol-Myers Squibb; HalioDx; Merck Serono; MSD Oncology; Novartis; Pierre Fabre
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - MSD Oncology
 
Zahir Amoura
No Relationships to Disclose
 
Jean-Philippe Spano
Consulting or Advisory Role - AstraZeneca; Biogaran Pharmaceuticals; Bristol-Myers Squibb; Gilead Sciences; Leo Pharma; Lilly; MSD; Mylan; Myriad Genetics; Novartis; Pfizer; Pfizer; Roche
Travel, Accommodations, Expenses - MSD; Pfizer; Roche
 
Julien Haroche
No Relationships to Disclose